OBJECTIVES - To establish a Prostate Cancer Outcomes Registry-Australia and New Zealand (PCOR-ANZ) for monitoring outcomes of prostate cancer treatment and care, in a cost-effective manner.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
MATERIALS AND METHODS - Stakeholders were recruited based on their interest, importance in achieving the monitoring and reporting of clinical practice and patient outcomes, and in amalgamation of existing registries.
Each participating jurisdiction is responsible for local governance, site recruitment, data collection, and data transfer into the PCOR-ANZ. To establish each local registry, hospitals and clinicians within a jurisdiction were approached to voluntarily contribute to the registry following relevant ethical approval. Patient contact occurs following notification of prostate cancer through a hospital or pathology report, or from a cancer registry. Patient registration is based on an opt-out model. The PCOR-ANZ is a secure web-based registry adhering to ISO 27001 standards. Based on a standardised minimum data set, information on demographics, diagnosis, treatment, outcomes, and patient reported quality of life, are collected.
RESULTS - Eight of nine jurisdictions have agreed to contribute to the PCOR-ANZ. Each jurisdiction has commenced implementation of necessary infrastructure to support rapid rollout. PCOR-ANZ has defined a minimum data set for collection, to enable analysis of key quality indicators that will aid in assessing clinical practice and patient focused outcomes.
CONCLUSIONS - PCOR-ANZ will provide a useful resource of risk-adjusted evidence-based data to clinicians, hospitals, and decision makers on prostate cancer clinical practice.
BJU international. 2016 Feb 15 [Epub ahead of print]
Sue M Evans, Nupur Nag, David Roder, Andrew Brooks, Jeremy L Millar, Kim L Moretti, David Pryor, Marketa Skala, John J McNeil
Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic. , Australia. , Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic. , Australia. , Centre for Population Health Research, University of South Australia, Adelaide, SA, Australia. , Department of Urology Westmead Hospital, Westmead, NSW, Australia. , Alfred Health Radiation Oncology, Melbourne, Vic, Australia. , Centre for Population Health Research, University of South Australia, Adelaide, SA, Australia. , Department of Radiation Oncology, Princess Alexandra Hospital, Wooloongabba, Qld, Australia. , WP Holman Clinic, Launceston, Tas. , Australia. , Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Vic. , Australia.